209 related articles for article (PubMed ID: 31185432)
1. Distribution and ecological risk of pharmaceuticals in surface water of the Yeongsan river, Republic of Korea.
Na TW; Kang TW; Lee KH; Hwang SH; Jung HJ; Kim K
Ecotoxicol Environ Saf; 2019 Oct; 181():180-186. PubMed ID: 31185432
[TBL] [Abstract][Full Text] [Related]
2. Study of pharmaceuticals in surface and wastewater from Cuernavaca, Morelos, Mexico: Occurrence and environmental risk assessment.
Rivera-Jaimes JA; Postigo C; Melgoza-Alemán RM; Aceña J; Barceló D; López de Alda M
Sci Total Environ; 2018 Feb; 613-614():1263-1274. PubMed ID: 28962074
[TBL] [Abstract][Full Text] [Related]
3. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea.
Choi K; Kim Y; Park J; Park CK; Kim M; Kim HS; Kim P
Sci Total Environ; 2008 Nov; 405(1-3):120-8. PubMed ID: 18684486
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of selected pharmaceuticals in the principal sewage treatment plants in Rome (Italy) and in the receiving surface waters.
Patrolecco L; Capri S; Ademollo N
Environ Sci Pollut Res Int; 2015 Apr; 22(8):5864-76. PubMed ID: 25352396
[TBL] [Abstract][Full Text] [Related]
5. Major pharmaceutical residues in wastewater treatment plants and receiving waters in Bangkok, Thailand, and associated ecological risks.
Tewari S; Jindal R; Kho YL; Eo S; Choi K
Chemosphere; 2013 Apr; 91(5):697-704. PubMed ID: 23332673
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and ecological risk of pharmaceuticals in river surface water of Bangladesh.
Hossain A; Nakamichi S; Habibullah-Al-Mamun M; Tani K; Masunaga S; Matsuda H
Environ Res; 2018 Aug; 165():258-266. PubMed ID: 29734026
[TBL] [Abstract][Full Text] [Related]
7. Colloids as a sink for certain pharmaceuticals in the aquatic environment.
Maskaoui K; Zhou JL
Environ Sci Pollut Res Int; 2010 May; 17(4):898-907. PubMed ID: 20024675
[TBL] [Abstract][Full Text] [Related]
8. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the ebro river basin (northeast Spain).
Gros M; Petrović M; Barceló D
Environ Toxicol Chem; 2007 Aug; 26(8):1553-62. PubMed ID: 17702326
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical compounds in tributaries of the Han River watershed, South Korea.
Im JK; Hwang MY; Lee EH; Noh HR; Yu SJ
Environ Res; 2020 Sep; 188():109758. PubMed ID: 32534256
[TBL] [Abstract][Full Text] [Related]
10. Prioritization of highly exposable pharmaceuticals via a suspect/non-target screening approach: A case study for Yeongsan River, Korea.
Park N; Choi Y; Kim D; Kim K; Jeon J
Sci Total Environ; 2018 Oct; 639():570-579. PubMed ID: 29800850
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal).
Madureira TV; Barreiro JC; Rocha MJ; Rocha E; Cass QB; Tiritan ME
Sci Total Environ; 2010 Oct; 408(22):5513-20. PubMed ID: 20732709
[TBL] [Abstract][Full Text] [Related]
12. Presence of pharmaceuticals in the Lis river (Portugal): Sources, fate and seasonal variation.
Paíga P; Santos LHMLM; Ramos S; Jorge S; Silva JG; Delerue-Matos C
Sci Total Environ; 2016 Dec; 573():164-177. PubMed ID: 27560998
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceuticals and environmental risk assessment in municipal wastewater treatment plants and rivers from Peru.
Nieto-Juárez JI; Torres-Palma RA; Botero-Coy AM; Hernández F
Environ Int; 2021 Oct; 155():106674. PubMed ID: 34174591
[TBL] [Abstract][Full Text] [Related]
14. Occurrences of pharmaceuticals in drinking water sources of major river watersheds, China.
Sun J; Luo Q; Wang D; Wang Z
Ecotoxicol Environ Saf; 2015 Jul; 117():132-40. PubMed ID: 25847753
[TBL] [Abstract][Full Text] [Related]
15. Temporal-spatial variation and environmental risk assessment of pharmaceuticals in tributaries of the Han River watershed, South Korea.
Im JK; Kim SH; Noh HR; Yu SJ
Sci Total Environ; 2020 Nov; 741():140486. PubMed ID: 32886987
[TBL] [Abstract][Full Text] [Related]
16. Suitability of passive sampling for the monitoring of pharmaceuticals in Finnish surface waters.
Lindholm-Lehto PC; Ahkola HS; Knuutinen JS; Koistinen J; Lahti K; Vahtera H; Herve SH
Environ Sci Pollut Res Int; 2016 Sep; 23(18):18043-54. PubMed ID: 27255325
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceuticals and iodinated contrast media in a hospital wastewater: A case study to analyse their presence and characterise their environmental risk and hazard.
Mendoza A; Aceña J; Pérez S; López de Alda M; Barceló D; Gil A; Valcárcel Y
Environ Res; 2015 Jul; 140():225-41. PubMed ID: 25880605
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China.
Zhao JL; Ying GG; Liu YS; Chen F; Yang JF; Wang L; Yang XB; Stauber JL; Warne MS
Environ Toxicol Chem; 2010 Jun; 29(6):1377-84. PubMed ID: 20821582
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceuticals in freshwater aquatic environments: A comparison of the African and European challenge.
Fekadu S; Alemayehu E; Dewil R; Van der Bruggen B
Sci Total Environ; 2019 Mar; 654():324-337. PubMed ID: 30448654
[TBL] [Abstract][Full Text] [Related]
20. Occurrence, ecological risk assessment and prioritization of pharmaceuticals and abuse drugs in estuarine waters along the São Paulo coast, Brazil.
Roveri V; Guimarães LL; Toma W; Correia AT
Environ Sci Pollut Res Int; 2022 Dec; 29(59):89712-89726. PubMed ID: 35857165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
